TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage

被引:29
作者
Kaduka, Y
Takeda, K [1 ]
Nakayama, M
Kinoshita, K
Yagita, H
Okumura, K
机构
[1] Juntendo Univ, Dept Immunol, Sch Med, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Obstet & Genecol, Tokyo 1138421, Japan
关键词
TWEAK; Fn14; apoptosis; tumor; macrophage;
D O I
10.1016/j.bbrc.2005.03.176
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TWEAK induces diverse cellular responses. including pro-inflammatory chemokine productions migration, proliferation, and cell death through the TWEAK receptor, Fn14. In the present Study we examined the effect of TWEAK or Fn 14 expression in tumor cells on tumor outgrowth in vivo. Administration of neutralizing anti-TWEAK mAb significantly reduced the frequency of tumor rejection and shortened the survival of mice intraperitoneally inoculated with TWEAK-sensitive Fn 14-expressing tumor cells. Moreover, anti-TWEAK mAb treatment promoted the subcutaneous growth of TWEAK-sensitive Fn 14-expressing tumor cells, and this promotion was abolished by the inhibition of macrophage infiltration but not NK cell depletion, In contrast, administration of anti-TWEAK mAb had no apparent effect on the growth of TWEAK-resistant tumor cells, even if tumor cells expressed Fn 14. On the other hand, TWEAK expression in tumor cells had no significant effect on subcutaneous tumor growth, These result, indicate that TWEAK mediates anti-tumor effect of macrophages in vivo. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:384 / 390
页数:7
相关论文
共 31 条
  • [1] The tumor necrosis factor ligand and receptor families
    Bazzoni, F
    Beutler, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1717 - 1725
  • [2] Signaling by the TNF receptor superfamily and T cell homeostasis
    Chan, FKM
    Siegel, RM
    Lenardo, MJ
    [J]. IMMUNITY, 2000, 13 (04) : 419 - 422
  • [3] TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
    Chicheportiche, Y
    Bourdon, PR
    Xu, HD
    Hsu, YM
    Scott, H
    Hession, C
    Garcia, I
    Browning, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32401 - 32410
  • [4] Cancer immunoediting: from immunosurveillance to tumor escape
    Dunn, GP
    Bruce, AT
    Ikeda, H
    Old, LJ
    Schreiber, RD
    [J]. NATURE IMMUNOLOGY, 2002, 3 (11) : 991 - 998
  • [5] ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE
    FOLKMAN, J
    [J]. NATURE MEDICINE, 1995, 1 (01) : 27 - 31
  • [6] Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL
    Griffith, TS
    Wiley, SR
    Kubin, MZ
    Sedger, LM
    Maliszewski, CR
    Fanger, NA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) : 1343 - 1353
  • [7] Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    Hanahan, D
    Folkman, J
    [J]. CELL, 1996, 86 (03) : 353 - 364
  • [8] Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells
    Harada, N
    Nakayama, M
    Nakano, H
    Fukuchi, Y
    Yagita, H
    Okumura, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (03) : 488 - 493
  • [9] Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice
    Ho, DH
    Vu, H
    Brown, SAN
    Donohue, PJ
    Hanscom, HN
    Winkles, JA
    [J]. CANCER RESEARCH, 2004, 64 (24) : 8968 - 8972
  • [10] Jakubowski A, 2002, J CELL SCI, V115, P267